Read the winning essay from the Young Science Writer of the Year 2024 award ...

The global self-monitoring blood glucose devices market was valued at $8,490.79 million in 2019, and is projected to reach $11,991.98 million by 2027, growing at a CAGR of 4.2% from 2020 to 2027.

Key Trends: Several trends shape the diabetes devices and drugs market in Saudi Arabia. These include the adoption of wearable technology for continuous glucose monitoring, the development of ...

Teladoc Health, one of the largest telehealth providers in the US, offers diabetes management to its members with expert ...

Embecta Corp. has notified the state that it intends to terminate 118 employees that work out of its facility at 200 Bulfinch ...

DUBLIN-- ( BUSINESS WIRE )--The "Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Blood Glucose Monitoring Devices ...

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

For years, glucose-sensitive membranes have been a key focus for improving controlled insulin release in diabetes treatments.

NuGen Medical Devices announced recently that it launched its InsuJet needle-free insulin delivery device in Canada.

Patients with type 1 diabetes were more likely to be prescribed continuous glucose monitoring compared with those with type 2 ...

With diabetes on the rise, people are increasingly turning to alert programs that combine innovative technology and connected devices with human coaches and support. Teladoc Health, one of the ...